In 2020, the European Commission stressed the importance of continuously monitoring the safety and effectiveness of vaccines in the EU/EEA during the post-authorisation phase, with particular emphasis on COVID-19 vaccines in the context of the ongoing pandemic.
This document aims to collate and present the lessons identified from the public health stakeholders who responded to the COVID-19 pandemic. It is intended to serve as input for countries revising their pandemic or emergency preparedness plans.
This document offers an overview of the available scientific evidence and epidemiological situation and provides public health considerations to support discussions and decisions on the planning and implementation of COVID-19 vaccination campaigns for 2023.
This document aims to support countries in designing after-action reviews (AARs) of the public health response to COVID-19. It has been designed to draw upon pre-existing ECDC guidance and follows a methodological approach combining interactive workshops and interviews. The Annexes feature practical implementation tools.
This document provides operational recommendations regarding the implementation of a set of measures that has been agreed by the Member States in the context of a precautionary approach to potential severe worsening of the COVID-19 epidemiological situation.
In order to explore how insights from the implementation of non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic may guide further preparedness for COVID-19 – as well as pandemic preparedness and response work in the EU more generally, ECDC organised an expert consultation in June 2022 on the implementation and evaluation of NPIs. This report summarises the findings from that consultation.
This protocol outlines the methods for a prospective cohort study in long-term care facilities (LTCFs) to evaluate the effectiveness of COVID-19 vaccines in preventing laboratory-confirmed SARS-CoV-2 symptomatic infection in LTCF residents.